位置:首页 > 蛋白库 > AROQ_MYCTU
AROQ_MYCTU
ID   AROQ_MYCTU              Reviewed;         147 AA.
AC   P9WPX7; L0TCT6; P0A4Z6; P36918; P95016;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   03-AUG-2022, entry version 46.
DE   RecName: Full=3-dehydroquinate dehydratase;
DE            Short=3-dehydroquinase;
DE            EC=4.2.1.10;
DE   AltName: Full=Type II DHQase;
GN   Name=aroQ; Synonyms=aroD; OrderedLocusNames=Rv2537c; ORFNames=MTCY159.19;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=1910148; DOI=10.1007/bf00260631;
RA   Garbe T., Servos S., Hawkins A., Dimitriadis G., Young D., Dougan G.,
RA   Charles I.G.;
RT   "The Mycobacterium tuberculosis shikimate pathway genes: evolutionary
RT   relationship between biosynthetic and catabolic 3-dehydroquinases.";
RL   Mol. Gen. Genet. 228:385-392(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [3]
RP   IDENTIFICATION AS A DRUG TARGET [LARGE SCALE ANALYSIS].
RX   PubMed=19099550; DOI=10.1186/1752-0509-2-109;
RA   Raman K., Yeturu K., Chandra N.;
RT   "targetTB: a target identification pipeline for Mycobacterium tuberculosis
RT   through an interactome, reactome and genome-scale structural analysis.";
RL   BMC Syst. Biol. 2:109-109(2008).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS), AND SUBUNIT.
RX   PubMed=10360352; DOI=10.1038/9287;
RA   Gourley D.G., Shrive A.K., Polikarpov I., Krell T., Coggins J.R.,
RA   Hawkins A.R., Isaacs N.W., Sawyer L.;
RT   "The two types of 3-dehydroquinase have distinct structures but catalyze
RT   the same overall reaction.";
RL   Nat. Struct. Biol. 6:521-525(1999).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) IN COMPLEX WITH POLYANION.
RX   PubMed=12387860; DOI=10.1016/s0014-5793(02)03346-x;
RA   Evans L.D., Roszak A.W., Noble L.J., Robinson D.A., Chalk P.A.,
RA   Matthews J.L., Coggins J.R., Price N.C., Lapthorn A.J.;
RT   "Specificity of substrate recognition by type II dehydroquinases as
RT   revealed by binding of polyanions.";
RL   FEBS Lett. 530:24-30(2002).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH SUBSTRATE ANALOGS.
RA   Robinson D.A., Roszak A.W., Frederickson M., Abell C., Coggins J.R.,
RA   Lapthorn A.J.;
RT   "Structural basis for specificity of oxime based inhibitors towards type II
RT   dehydroquinase from Mycobacterium tuberculosis.";
RL   Submitted (MAY-2004) to the PDB data bank.
CC   -!- FUNCTION: Catalyzes a trans-dehydration via an enolate intermediate.
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-dehydroquinate = 3-dehydroshikimate + H2O;
CC         Xref=Rhea:RHEA:21096, ChEBI:CHEBI:15377, ChEBI:CHEBI:16630,
CC         ChEBI:CHEBI:32364; EC=4.2.1.10;
CC   -!- PATHWAY: Metabolic intermediate biosynthesis; chorismate biosynthesis;
CC       chorismate from D-erythrose 4-phosphate and phosphoenolpyruvate: step
CC       3/7.
CC   -!- SUBUNIT: Homododecamer. {ECO:0000269|PubMed:10360352,
CC       ECO:0000269|PubMed:12387860, ECO:0000269|Ref.7}.
CC   -!- MISCELLANEOUS: Was identified as a high-confidence drug target.
CC   -!- SIMILARITY: Belongs to the type-II 3-dehydroquinase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X59509; CAA42096.1; -; Genomic_DNA.
DR   EMBL; AL123456; CCP45332.1; -; Genomic_DNA.
DR   PIR; E70658; E70658.
DR   RefSeq; NP_217053.1; NC_000962.3.
DR   RefSeq; WP_003413001.1; NZ_NVQJ01000032.1.
DR   PDB; 1H05; X-ray; 1.50 A; A=2-147.
DR   PDB; 1H0R; X-ray; 2.10 A; A=2-147.
DR   PDB; 1H0S; X-ray; 1.70 A; A=2-147.
DR   PDB; 2DHQ; X-ray; 2.00 A; A=2-147.
DR   PDB; 2XB8; X-ray; 2.40 A; A=2-147.
DR   PDB; 2Y71; X-ray; 1.50 A; A=2-147.
DR   PDB; 2Y76; X-ray; 2.50 A; A=2-147.
DR   PDB; 2Y77; X-ray; 1.50 A; A=2-147.
DR   PDB; 3N59; X-ray; 2.52 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-147.
DR   PDB; 3N76; X-ray; 1.90 A; A=1-147.
DR   PDB; 3N7A; X-ray; 2.00 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-147.
DR   PDB; 3N86; X-ray; 1.90 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-147.
DR   PDB; 3N87; X-ray; 2.40 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-147.
DR   PDB; 3N8K; X-ray; 2.25 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-147.
DR   PDB; 3N8N; X-ray; 2.50 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-147.
DR   PDB; 4B6O; X-ray; 2.00 A; A=2-147.
DR   PDB; 4B6P; X-ray; 2.30 A; A=2-147.
DR   PDB; 4B6Q; X-ray; 1.54 A; A=2-147.
DR   PDB; 4CIV; X-ray; 2.90 A; A=2-147.
DR   PDB; 4CIW; X-ray; 2.20 A; A=2-147.
DR   PDB; 4CIX; X-ray; 2.90 A; A=2-147.
DR   PDB; 4CIY; X-ray; 2.10 A; A=2-147.
DR   PDB; 4CKW; X-ray; 2.70 A; A/B/C/D=2-147.
DR   PDB; 4CKX; X-ray; 2.60 A; A=2-147.
DR   PDB; 4CKY; X-ray; 1.65 A; A=2-147.
DR   PDB; 4CKZ; X-ray; 2.52 A; A/B=2-147.
DR   PDB; 4CL0; X-ray; 3.10 A; A=2-147.
DR   PDB; 4KI7; X-ray; 2.80 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-147.
DR   PDB; 4KIJ; X-ray; 2.80 A; A=1-147.
DR   PDB; 4KIU; X-ray; 2.40 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-147.
DR   PDB; 4KIW; X-ray; 2.57 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-147.
DR   PDB; 4V0S; X-ray; 1.55 A; A/B=2-147.
DR   PDBsum; 1H05; -.
DR   PDBsum; 1H0R; -.
DR   PDBsum; 1H0S; -.
DR   PDBsum; 2DHQ; -.
DR   PDBsum; 2XB8; -.
DR   PDBsum; 2Y71; -.
DR   PDBsum; 2Y76; -.
DR   PDBsum; 2Y77; -.
DR   PDBsum; 3N59; -.
DR   PDBsum; 3N76; -.
DR   PDBsum; 3N7A; -.
DR   PDBsum; 3N86; -.
DR   PDBsum; 3N87; -.
DR   PDBsum; 3N8K; -.
DR   PDBsum; 3N8N; -.
DR   PDBsum; 4B6O; -.
DR   PDBsum; 4B6P; -.
DR   PDBsum; 4B6Q; -.
DR   PDBsum; 4CIV; -.
DR   PDBsum; 4CIW; -.
DR   PDBsum; 4CIX; -.
DR   PDBsum; 4CIY; -.
DR   PDBsum; 4CKW; -.
DR   PDBsum; 4CKX; -.
DR   PDBsum; 4CKY; -.
DR   PDBsum; 4CKZ; -.
DR   PDBsum; 4CL0; -.
DR   PDBsum; 4KI7; -.
DR   PDBsum; 4KIJ; -.
DR   PDBsum; 4KIU; -.
DR   PDBsum; 4KIW; -.
DR   PDBsum; 4V0S; -.
DR   AlphaFoldDB; P9WPX7; -.
DR   SMR; P9WPX7; -.
DR   STRING; 83332.Rv2537c; -.
DR   BindingDB; P9WPX7; -.
DR   ChEMBL; CHEMBL3345; -.
DR   DrugBank; DB02801; 2,3-Anhydro-quinic acid.
DR   DrugBank; DB03739; 3-Hydroxyimino Quinic Acid.
DR   PaxDb; P9WPX7; -.
DR   DNASU; 888397; -.
DR   GeneID; 888397; -.
DR   KEGG; mtu:Rv2537c; -.
DR   TubercuList; Rv2537c; -.
DR   eggNOG; COG0757; Bacteria.
DR   OMA; AYTHYSY; -.
DR   PhylomeDB; P9WPX7; -.
DR   BRENDA; 4.2.1.10; 3445.
DR   Reactome; R-MTU-964903; Chorismate via Shikimate Pathway.
DR   UniPathway; UPA00053; UER00086.
DR   PRO; PR:P9WPX7; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0003855; F:3-dehydroquinate dehydratase activity; IDA:MTBBASE.
DR   GO; GO:0009073; P:aromatic amino acid family biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0008652; P:cellular amino acid biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0009423; P:chorismate biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0019631; P:quinate catabolic process; IBA:GO_Central.
DR   CDD; cd00466; DHQase_II; 1.
DR   Gene3D; 3.40.50.9100; -; 1.
DR   HAMAP; MF_00169; AroQ; 1.
DR   InterPro; IPR001874; DHquinase_II.
DR   InterPro; IPR018509; DHquinase_II_CS.
DR   InterPro; IPR036441; DHquinase_II_sf.
DR   PANTHER; PTHR21272; PTHR21272; 1.
DR   Pfam; PF01220; DHquinase_II; 1.
DR   PIRSF; PIRSF001399; DHquinase_II; 1.
DR   SUPFAM; SSF52304; SSF52304; 1.
DR   TIGRFAMs; TIGR01088; aroQ; 1.
DR   PROSITE; PS01029; DEHYDROQUINASE_II; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Amino-acid biosynthesis; Aromatic amino acid biosynthesis;
KW   Lyase; Reference proteome.
FT   CHAIN           1..147
FT                   /note="3-dehydroquinate dehydratase"
FT                   /id="PRO_0000159910"
FT   ACT_SITE        25
FT                   /note="Proton acceptor"
FT   ACT_SITE        102
FT                   /note="Proton donor"
FT   BINDING         76
FT                   /ligand="substrate"
FT   BINDING         82
FT                   /ligand="substrate"
FT   BINDING         89
FT                   /ligand="substrate"
FT   BINDING         103..104
FT                   /ligand="substrate"
FT   BINDING         113
FT                   /ligand="substrate"
FT   SITE            20
FT                   /note="Transition state stabilizer"
FT   CONFLICT        117
FT                   /note="Y -> I (in Ref. 1; CAA42096)"
FT                   /evidence="ECO:0000305"
FT   TURN            1..3
FT                   /evidence="ECO:0007829|PDB:4KI7"
FT   STRAND          5..10
FT                   /evidence="ECO:0007829|PDB:1H05"
FT   HELIX           14..16
FT                   /evidence="ECO:0007829|PDB:1H05"
FT   TURN            17..19
FT                   /evidence="ECO:0007829|PDB:1H05"
FT   TURN            23..25
FT                   /evidence="ECO:0007829|PDB:2Y71"
FT   STRAND          26..28
FT                   /evidence="ECO:0007829|PDB:4CIY"
FT   HELIX           30..43
FT                   /evidence="ECO:0007829|PDB:1H05"
FT   STRAND          47..52
FT                   /evidence="ECO:0007829|PDB:1H05"
FT   HELIX           56..69
FT                   /evidence="ECO:0007829|PDB:1H05"
FT   STRAND          73..76
FT                   /evidence="ECO:0007829|PDB:1H05"
FT   HELIX           78..82
FT                   /evidence="ECO:0007829|PDB:1H05"
FT   HELIX           85..92
FT                   /evidence="ECO:0007829|PDB:1H05"
FT   STRAND          98..104
FT                   /evidence="ECO:0007829|PDB:1H05"
FT   HELIX           106..108
FT                   /evidence="ECO:0007829|PDB:1H05"
FT   HELIX           111..114
FT                   /evidence="ECO:0007829|PDB:1H05"
FT   HELIX           119..121
FT                   /evidence="ECO:0007829|PDB:1H05"
FT   STRAND          122..129
FT                   /evidence="ECO:0007829|PDB:1H05"
FT   HELIX           132..143
FT                   /evidence="ECO:0007829|PDB:1H05"
SQ   SEQUENCE   147 AA;  15790 MW;  9EE0E1B14B4DB5F6 CRC64;
     MSELIVNVIN GPNLGRLGRR EPAVYGGTTH DELVALIERE AAELGLKAVV RQSDSEAQLL
     DWIHQAADAA EPVILNAGGL THTSVALRDA CAELSAPLIE VHISNVHARE EFRRHSYLSP
     IATGVIVGLG IQGYLLALRY LAEHVGT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024